This publications portal is a repository of all IOM migration health publications from 2006 to present where IOM was a primary contributor.
Publications include peer-reviewed scientific papers, technical reports, training guides/manuals, policy briefs/discussion papers, factsheets, newsletters, research reviews, conference and poster presentations. These are categorized by topic, author, country/region covered as well as by year, language, and type of publication. The map reflects the countries covered by the publications.
To browse or search: simply use the filter options on the left-hand side. Alternatively, you can enter keyword/s in the search box. Selecting a specific publication will lead to a ‘download’ link or link to the website where the document is housed. Here is the step-by-step guide for your reference.
Introducing new tuberculosis diagnostics: the impact of Xpert MTB/ RIF testing on case notifications in Nepal
Author/s: Jacob Creswell, B Rai, R Wali, S Sudrungrot, LM Adhikari, R Pant, S Pyakurel, D Uranw, AJ Codlin
SETTING: The Xpert® MTB/RIF assay is a highly sensitive molecular test with the potential to improve tuberculosis (TB) case detection. However, evidence supporting this potential at a programme level is minimal.
METHODS: Xpert testing following smear microscopy and chest X-ray was implemented as part of routine case finding in 16 districts of Eastern Nepal. Changes in TB case notification were evaluated based on a pre/post analysis, as were expected notifications…Read more
Author/s: Jacob Creswell, Andrew Collins, Emmanuel Andre, Mark Micek, Ahmed Bedru, E Jane Carter, Rajendra-Prasa Yadav, Andrei Mosneaga, Bishwa Raj, Sayera Banu, Miranda Brouwer, Lucie Blok, Suvanand Sahu, Lucica Ditiu
Background: The Xpert MTB/RIF assay has garnered significant interest as a sensitive and rapid diagnostic tool to improve detection of sensitive and drug resistant tuberculosis. However, most existing literature has described the performance of MTB/RIF testing only in study conditions; little information is available on its use in routine case finding. TB REACH is a multi-country initiative focusing on innovative ways to improve case notification.